A Phase 2 Open-Label Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with High-Grade Serous Ovarian Fallopian Tube or Primary Peritoneal Cancer (ZN-c3-005 GOG 3066)
Indication: Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer
Trial Number: 05128825
Trial Status: OPEN